The energy market is very ‘jaded’ from trading geopolitics, says Energy Aspects’ Amrita SenOctober 14, 2024
Share Facebook Twitter LinkedIn Pinterest Email Ritu Baral, TD Cowen Sr. Biotechnology Analyst, joins ‘Closing Bell Overtime’ to talk Sarepta’s approval from the FDA for its Duchenne gene therapy and how it drove the stock to its best trading day in a year.